NCT02428725View on ClinicalTrials.gov

Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome

NACompletedINTERVENTIONAL

Enrollment

640

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions

Acute Coronary Syndrome

Interventions

OTHER

blood sample

Biological samples will be done to determine platelet reactivity testing by VASP-index, will be obtained between 6 and 12 hours after receiving ticagrelor

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02428725 - Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome | Biotech Hunter | Biotech Hunter